MojunZhuMD

Oncology • Rochester, MN

Gastrointestinal Cancer

GI Oncologist

Join to view full profile

Dr. Zhu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Zhu's full profile

Already have an account?

Office
200 1st St SW
Rochester, MN 55905
Phone+1 507-284-2511

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2018 - 2021
Yale-New Haven Medical CenterResidency, Internal Medicine, 2015 - 2018
Yale School of MedicineClass of 2015

Certifications & Licensure

MN State Medical License 2018 - 2026
CT State Medical License 2017 - 2018
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Young Investigator Award American Society of Clinical Oncology (ASCO), 2020
Outstanding Hematology/Oncology Fellow Award Minnesota Society of Clinical Oncology (MSCO), 2020

Publications & Presentations

PubMed

Comparison of survival outcomes for patients with Lynch vs non-Lynch syndrome and microsatellite unstable colorectal cancer treated with immunotherapy.
Cody Eslinger, Daniel Walden, Alyssa McGary, Oluwadunni Emiloju, Daniel Ahn
Cancer. 2025-02-15
Advances in Immunotherapy in Esophagogastric Cancer.
Khalid Jazieh, Harry Yoon, Mojun Zhu
Hematology/oncology Clinics of North America. 2024-06-01
12 citations
Microfluidic Organoid Cultures Derived from Pancreatic Cancer Biopsies for Personalized Testing of Chemotherapy and Immunotherapy.
Daheui Choi, Alan M Gonzalez-Suarez, Mihai G Dumbrava, Michael Medlyn, Jose M de Hoyos-Vega
Advanced Science. 2024-02-01

Lectures

Meta-analysis of prognostic biomarkers for pancreatic neuroendocrine tumors (PNETs).
2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

As Stomach Cancer Rates Rise in Younger People, Knowing Symptoms and Family History Is KeyFebruary 11th, 2025
Chemoimmunotherapy Improves Pathologic Outcomes in Gastroesophageal CarcinomaNovember 25th, 2023